Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 151Lung Neoplasms 34Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Neoplasms 9Neoplasm Metastasis 9Mesothelioma 5Adenocarcinoma of Lung 5Uterine Cervical Neoplasms 4Thoracic Neoplasms 4Respiratory Tract Neoplasms 4Respiratory Tract Diseases 4Mesothelioma, Malignant 4Lung Diseases 4Carcinoma, Bronchogenic 4Non-squamous Non-small Cell Lung Cancer 3Non-Squamous Non-Small Cell Lung Cancer 3Neoplasms by Site 3NSCLC 3Bronchial Neoplasms 3Adenocarcinoma 3Recurrence 2Non-Squamous Non-small Cell Lung Cancer 2Non Small Cell Lung Carcinoma NSCLC 2Head and Neck Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1

Interventions

atezolizumab 1Pemetrexed 1Gemcitabine 1Cisplatin 1Carboplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Non-Small-Cell Lung × Pemetrexed × Clear all
NCT03456063 2026-01-22

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Hoffmann-La Roche

Phase 3 Completed
453 enrolled
Thoracic

Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡